• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

MetaStat lands $7m for personalized cancer diagnostic, therapy tech

June 29, 2017 By Sarah Faulkner

MetaStatMetaStat (OTC:MTST) said this week that it closed the 1st tranche of a $7 million private placement.

The round, which was led by Perceptive Advisors, is slated to bring in approximately $2.1 million, according to the Boston-based company.

The private placement consisted of an aggregate of 690,816 shares of common stock and 196,216 shares of convertible preferred stock, which are convertible into 1,962,164 shares of common stock.

In connection with the offering, the company adjusted the exercise price of 474,829 outstanding common stock purchase warrants from $3.00 apiece to $2.00 per share.

MetaStat has until the end of July to finish the private placement.

The biotech is developing a personalized therapeutics and diagnostic treatment solutions for patients with cancer. The company said its diagnostic biomarkers can also act as novel therapeutics targets for anti-metastatic drugs.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diagnostics, Featured, Funding Roundup, Oncology, Pharmaceuticals Tagged With: metastat

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS